Belotero is the world’s first monophasic hyaluronic acid dermal filler with patented CPM technology and was recently approved by the FDA. Translation: Belotero can be injected more superficially (not as deeply) than the current dermal fillers that are available, without being visable. Superficial and fine lines can be treated with Belotero without threat of the bluish tint that can often occur with Restylane or Juvederm
Belotero’s unique structure completely fills the dermal spaces and produces a lasting natural cosmetic effect with smooth transitions between treated and untreated areas. The length of time that Belotero lasts depends on the individual and the area that has been treated.
In clinical studies 66% of patients continued to show a visible improvement 9 months after a single treatment. Most clients opt for follow-up treatments after 6 to 12 months to maintain a fresh, youthful appearance.
We are proud to have been chosen by Merz Aesthetics as one of the few offices it has initially selected to offer Belotero to. Learn more about Belotero at www.drgailhumble.com today, or fill out the form in the top left corner.